3Loutzenhiser R,Bidani AK, Wang X. Systolic pressure and the myogenic response of the renal afferent arteriole [J]. Acta Physiol Seand, 2004,181 (4) : 407-413.
5Krag S, Osterby R, Chai Q, et al. TGF-betal-induced glomerular disorder is associated with impaired concentrating ability mimicking primary glomerular disease with renal failure in man[J]. Lab Invest,2000,80(12):1855-1868.
6Li B, Khanna A, Sharma V, et al. TGF-betal DNA polymorphisms, proteinlevels, and blood pressure [ J ]. Hypertension,1999,33(1 Pt 1) :271-275.
5Mule G, Cottone S, Nardi E, et al. Metabolic syndrome in subjects with essential hypertension:relationships with subclinical cardiovascular and renal damage[ J]. Minewa Cardioangiologica, 2006, 54 (2) : 173-194.
6Wolf G, Ziyadeh FN. Leptin and renal fibrosis[ J]. Contributions to Nephrology, 2006, 151: 175-183.
7Cambien f,Ricard s,Troesch A,et al.Polymorphisms of the transforming growth factor-β1 gene in relation to myocardial infarction and blood pressure[J].Hypertension,1996,28(5):881-887.
8Jovanovié Z,Crncevié-Orli Z,Stimac D,et al.Effects of obesity reduction on cardiovascular risk factors:comparison of individual and group treatment-substudy of the Croatian Healthy Weight Loss Programme[J].Coll Antropol 2009,33(3):751-757.
9Nomata Y,Kume N,Sasai H,et al.Weight reduction can decrease circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in overweight middle-aged men[J].Metabolism,2009,58(9):1209-1214.
10Veber V P,Kazymov M S,Kopina M N,et al.Age and sex-related prevalence of overweight,arterial hypertension,hyperglycemia and their combina[J].Ter Arkh.2008,80(9):76-78.
2MacKinnon KL, Molnar Z, Lowe D, et al. Use of microalbuminuria as a predictor of outcome in critically ill patients[J]. Br J Anaesth,2000, 84(2) :239-241.
3Mutunga M, Fulton B, Bullock R, et al. Circulating endothelial cells in patients with septic shock[J].Am J Respir Crit Care Med,2001,163(1) :195-200.
4Gerstein HC,Mann JF,Yi Q, et al. Albuminuria and risk of cardiovascular events, death,and heart failure in diabetic and non-diabetic individuals[J]. JAMA,2001,286(4) :421-426.
5Abid O, Sun Q, Sugimoto K, et al. Predictive value of microalbuminuria in medical ICU patients:Results of a pilot study[J]. Chest, 2001,120(6) : 1984-1988.
6Gosling P,Brudney S, McGrath L, et al. Mortality prediction at admission to intensive care: A comparison of microalbuminuria with acute physiology scores after 24 hours [J]. Crit Care Meal,2003,31(1) :98-103.
7Pan,XD, Zeng,ZH, Liang LY, et al .The effects of simvas- tatin on left ventricular hypertrophy and left ventricu|ar func- tion in patients with essential hypertension [J]. Clin Exp Hypertens, 2011,33(8) :558-564.
8Chang, TY, Liu CS, Young LH, et al . Noise frequency compo- nents and the prevalence of hypertension in workers[J]. Sci Total Environ, 2012,416:89-96.
9Wang XC, Liu CH, Chen YJ, et al. Clinical and pathological analysis of the kidney in patients with hypertensive nephropathy [ J]. Exp Ther Med, 2013,6 (5) : 1243 - 1246.
10Abd E1 Motteleb DM, Elshazly SM. Renoprotective effect of sitagliptin against hypertensive nephrolathy induced by chronic administration of L - NAME in rats:role of GLP - 1 and GLP - 1 receptor[ J]. Eur J Phar- macol, 2013,720( 1 -3) :158 - 165.
